Health
New review of the first oral PCSK9 drug, a needle-free option for high cholesterol
Headline as filed by Medical Xpress.
Compare coverage — 1 report
| Publisher | Headline | Summary | Published | Detected | Delay | Source | Status |
|---|---|---|---|---|---|---|---|
| Medical Xpress | New review of the first oral PCSK9 drug, a needle-free option for high cholesterol |
A new review from Binghamton University School of Pharmacy and Pharmaceutical Science explores how Lipfendra (enlicitide) can be beneficial for those who have intolerances to injectable medications. T |
0m | medicalxpress.com | First |
Headlines and summaries belong to the publisher named beside them. “Published” is what their feed stated; “detected” is when PageNews first held the report. Delay is measured from the earliest report on this event and describes timing only.
Reader comments
Comments are written by readers. PageNews does not check them and does not stand behind them, and a name here is a name someone typed, not a person we have identified.
Nobody has commented on this story yet.